News | SK Capital

All News

Halo Pharmaceutical

Halo Pharma Emerges as Standalone CDMO Following Siegfried Acquisition of Noramco

May 8, 2026

Phoenix

SK Capital Partners Completes the Sale of Phoenix Flavors & Fragrances to Turpaz Industries

May 4, 2026

Noramco

SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG

May 1, 2026

New Hire

SK Capital Partners Appoints Jason Grapski as Managing Director, Portfolio Excellence

April 30, 2026

Apotex

Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses

April 24, 2026

Acquisitions, Brothers

SK Capital Acquires Brothers International

April 22, 2026

Load More